Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03485651 · ClinicalTrials.gov registry record
Natera Ovarian Cancer Detection Assay
A clinical trial, sponsored by Natera.
- Terminated
- Registry status
- 12
- Enrollment target
NCT03485651 is a clinical trial that was terminated before completion, run by Natera. The registered enrollment target is 12 participants.
The verdict
NCT03485651 was terminated before completion, sponsored by Natera.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to enroll participants who present with an adnexal mass on imaging to develop a non-invasive ovarian cancer assay to distinguish between malignant and benign masses. The study will collect blood, tissue, and health information from these individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03485651
The ClinicalTrials.gov registry entry for NCT03485651 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03485651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03485651 about?
NCT03485651 is a clinical study titled "Natera Ovarian Cancer Detection Assay". The purpose of this study is to enroll participants who present with an adnexal mass on imaging to develop a non-invasive ovarian cancer assay to distinguish between malignant and benign masses. The study will collect blood, tissue, and health information from these individuals.
What is the current status of trial NCT03485651?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2017-12-14. Estimated completion is 2019-12-31.
Who is sponsoring clinical trial NCT03485651?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.